BR112013011012A2 - métodos e composições - Google Patents

métodos e composições

Info

Publication number
BR112013011012A2
BR112013011012A2 BR112013011012A BR112013011012A BR112013011012A2 BR 112013011012 A2 BR112013011012 A2 BR 112013011012A2 BR 112013011012 A BR112013011012 A BR 112013011012A BR 112013011012 A BR112013011012 A BR 112013011012A BR 112013011012 A2 BR112013011012 A2 BR 112013011012A2
Authority
BR
Brazil
Prior art keywords
compositions
methods
peg
prevention
treatment
Prior art date
Application number
BR112013011012A
Other languages
English (en)
Portuguese (pt)
Inventor
Corinne De Vries
Ian Cox
Jörg Plessl
Leighton Jones
Peter Stein
Rachel Charlton
Samuel Smith
Original Assignee
Norgine Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norgine Bv filed Critical Norgine Bv
Publication of BR112013011012A2 publication Critical patent/BR112013011012A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • A61K31/77Polymers containing oxygen of oxiranes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
BR112013011012A 2010-11-04 2011-11-04 métodos e composições BR112013011012A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1018650.0A GB201018650D0 (en) 2010-11-04 2010-11-04 Methods and compositions
US41212810P 2010-11-10 2010-11-10
PCT/GB2011/001561 WO2012059725A1 (en) 2010-11-04 2011-11-04 Peg or peg block copolymers for treating colorectal cancer

Publications (1)

Publication Number Publication Date
BR112013011012A2 true BR112013011012A2 (pt) 2016-08-23

Family

ID=43414365

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013011012A BR112013011012A2 (pt) 2010-11-04 2011-11-04 métodos e composições

Country Status (22)

Country Link
US (2) US20130216493A1 (enExample)
EP (1) EP2635289B1 (enExample)
JP (1) JP5917537B2 (enExample)
KR (1) KR20130109171A (enExample)
CN (1) CN103313719A (enExample)
AR (1) AR083770A1 (enExample)
AU (1) AU2011324996B2 (enExample)
BE (1) BE1019494A3 (enExample)
BR (1) BR112013011012A2 (enExample)
CA (1) CA2816839A1 (enExample)
EA (1) EA201300540A1 (enExample)
ES (1) ES2401269B1 (enExample)
GB (1) GB201018650D0 (enExample)
MX (1) MX349690B (enExample)
MY (1) MY163067A (enExample)
NL (1) NL2007715C2 (enExample)
NZ (1) NZ611145A (enExample)
SG (1) SG189533A1 (enExample)
TW (1) TWI606832B (enExample)
UA (1) UA107998C2 (enExample)
WO (1) WO2012059725A1 (enExample)
ZA (1) ZA201304052B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI535461B (zh) 2011-03-11 2016-06-01 諾金私人有限公司 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法
NZ743984A (en) 2012-09-11 2019-10-25 Norgine Bv Compositions comprising polyethylene glycol, alkali metal or alkaline earth metal sulphates and electrolytes for use as colon cleansing compositions
AR093153A1 (es) * 2012-10-26 2015-05-20 Northshore Univ Healthsystem Composiciones que comprenden polietilenglicol para la terapia del carcinoma de celulas escamosas de cabeza y cuello
CN103083733A (zh) * 2013-02-19 2013-05-08 华熙福瑞达生物医药有限公司 一种医用体腔器械导入水性润滑剂
CN113507933B (zh) * 2019-03-05 2024-05-10 陶氏环球技术有限责任公司 诱导胱天蛋白酶活性
CN113473996B (zh) 2019-03-05 2024-05-24 陶氏环球技术有限责任公司 诱导胱天蛋白酶活性
JP7487220B2 (ja) * 2019-03-05 2024-05-20 ダウ グローバル テクノロジーズ エルエルシー カスパーゼ活性を誘導するためのポリエチレングリコール誘導体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2784897B1 (fr) 1998-10-27 2002-11-29 Agronomique Inst Nat Rech Utilisation d'un laxatif osmotique non fermente dans le traitement et la prevention des cancers colorectaux
WO2006122104A1 (en) * 2005-05-06 2006-11-16 Salix Pharmaceuticals, Inc. Polyethylene glycol colonic purgative composition
US8457025B2 (en) * 2009-08-28 2013-06-04 Telefonaktiebolaget L M Ericsson (Publ) Method and network node for selecting a network prefix to be advertised in a communication network

Also Published As

Publication number Publication date
AU2011324996B2 (en) 2015-10-08
EP2635289A1 (en) 2013-09-11
MX349690B (es) 2017-08-09
TW201304785A (zh) 2013-02-01
WO2012059725A8 (en) 2013-05-30
MX2013004963A (es) 2013-08-27
ES2401269A1 (es) 2013-04-18
AR083770A1 (es) 2013-03-20
CA2816839A1 (en) 2012-05-10
ES2401269B1 (es) 2014-02-19
CN103313719A (zh) 2013-09-18
ZA201304052B (en) 2014-02-26
UA107998C2 (uk) 2015-03-10
EA201300540A1 (ru) 2013-09-30
BE1019494A3 (fr) 2012-07-03
EP2635289B1 (en) 2020-03-11
TWI606832B (zh) 2017-12-01
WO2012059725A1 (en) 2012-05-10
JP2013544809A (ja) 2013-12-19
JP5917537B2 (ja) 2016-05-18
US20160228467A1 (en) 2016-08-11
NL2007715A (en) 2012-05-07
SG189533A1 (en) 2013-05-31
KR20130109171A (ko) 2013-10-07
GB201018650D0 (en) 2010-12-22
AU2011324996A1 (en) 2013-05-02
NZ611145A (en) 2015-07-31
MY163067A (en) 2017-08-15
US20130216493A1 (en) 2013-08-22
NL2007715C2 (en) 2012-10-16

Similar Documents

Publication Publication Date Title
BR112013011012A2 (pt) métodos e composições
CY1122187T1 (el) Αντιγονικη συνθεση μυκοβακτηριου
BR112015007878A2 (pt) composto compreendendo oligonucleotídeo modificado, composição, combinação e uso dos mesmos
CY1125152T1 (el) Συνθεσεις και μεθοδοι για τη μειωση της νεοαγγειωσης του οφθαλμου
CL2013000018A1 (es) Compuestos derivados de indolizina , su procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento del cancer, entre otros.
BR112015015319A2 (pt) composições de nanopartícula de albumina e paclitaxel
EA201200951A1 (ru) Определенные триазолопиридины и триазолопиразины, их композиции и способы их применения
PH12013500441A1 (en) Materials and methods for improving gastrointestinal function
JO3283B1 (ar) تركيب يتضمن أفليبيرسيبت, حمض فولينيك, 5- فلورويوراسيل (5- Fu) وإرينوسيتان (FOLFIRI)
BR112012011485A2 (pt) "composições e métodos para tratar náusea e vômito centralmente mediados".
EA201590987A1 (ru) Соединения и способы их применения
PH12013500713A1 (en) Antitussive compositions comprising memantine
MX2013003162A (es) Composicion farmaceutica.
BR112014021531A2 (pt) composto, composição farmacêutica e usos dos mesmos
TR200806298A2 (tr) Farmasötik formülasyon
BR112012016468A2 (pt) estabilização de filme de óxido de zinco em composições orais.
WO2009131730A3 (en) IMMUNOGENIC COMPOSITIONS FOR ACTIVATING γδ T CELLS
BR112015000246A2 (pt) composições de copolímero de olefina-anidrido maleico e usos destas
BR112014014800A2 (pt) composições de cuidado oral
PH12015501088A1 (en) Dimeric compounds
WO2011123678A3 (en) Substituted benzo-pyrido-triazolo-diazepine compounds
WO2009095261A3 (en) Vaccine compositions
PH12013501311A1 (en) Polymer systems
WO2009114461A3 (en) Angiotensin (1-7) dosage forms and uses thereof
BR112015020079A2 (pt) composições para cuidado oral

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2538 DE 27-08-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B350 Update of information on the portal [chapter 15.35 patent gazette]